Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984732 · ClinicalTrials.gov registry record · NA
Intergenerational Reminiscence and Digital Storytelling
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT05984732 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 206 participants.
The verdict
NCT05984732, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to develop and test how reminiscence offered by trained young adult volunteers using a digital storytelling (DST) platform may help older persons with Alzheimer's disease and related dementias (ADRD) to improve their social and emotional well-being. The main questions it aims to answer are: 1. Whether is this reminiscence and DST based intervention effective in improving social and emotional well-being of older adults with ADRD? 2. Whether do young adult participants improve their social and emotional well-being as well as knowledge and attitudes towards aging after participating this study? Older adult participants in the intervention group will receive 6 sessions of life-review with young adult volunteers and create a DST based on their life review discussion in the last 4 weeks. Older adult participants in the social wellness control group will receive 6 sessions of general talks with young adults and create a non-digital scrapbook or journal at week 7-10. Researchers will compare these two groups to see if participants in the intervention group benefit more on their well-being.
Interventions
- BEHAVIORAL Reminiscence with digital storytelling
- BEHAVIORAL Social wellness with scrapbook or journal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05984732
The ClinicalTrials.gov registry entry for NCT05984732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reminiscence with digital storytelling is the first listed.
NCT05984732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05984732 about?
NCT05984732 is a clinical study titled "Intergenerational Reminiscence and Digital Storytelling". The goal of this clinical trial is to develop and test how reminiscence offered by trained young adult volunteers using a digital storytelling (DST) platform may help older persons with Alzheimer's disease and related dementias (ADRD) to improve their social and emotional well-being. The main questi...
What is the current status of trial NCT05984732?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2021-04-15. Estimated completion is 2022-08-30.
What interventions are being tested in trial NCT05984732?
The interventions under investigation include: Reminiscence with digital storytelling (BEHAVIORAL), Social wellness with scrapbook or journal (BEHAVIORAL).
Who is sponsoring clinical trial NCT05984732?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.